A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1998
12/30/1998	EP0887081A2 Human serum glucocorticoid regulated kinase, a target for chronic renal disease
12/30/1998	EP0886679A1 Parapoxviruses containing foreign dna, their production and their use in vaccines
12/30/1998	EP0886677A1 Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound
12/30/1998	EP0886652A1 Pulmonary surfactant peptide solubilization process
12/30/1998	EP0886651A1 Persephin and related growth factors
12/30/1998	EP0886650A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions
12/30/1998	EP0886648A1 Compounds and peptides that bind to the erythropoietin receptor
12/30/1998	EP0886647A1 Serine protease inhibitors
12/30/1998	EP0886646A1 Novel compounds
12/30/1998	EP0886642A1 Immune cell cytokine
12/30/1998	EP0886527A1 PHARMACEUTICAL COMPOSITIONS COMPRISING NATURAL HUMAN $g(a)-INTERFERON
12/30/1998	EP0886526A1 Protection of hemopoietic cells
12/30/1998	EP0886525A1 PROGRAMMED CELL DEATH AND INTERLEUKIN-1$g(b)
12/30/1998	EP0886524A2 Delivery of therapeutic agents to the prostate
12/30/1998	EP0760661B1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
12/30/1998	EP0750637B1 Dna encoding cai resistance proteins and uses thereof
12/30/1998	EP0724433B1 Method for preparing microspheres comprising a fluidized bed drying step
12/30/1998	EP0700443B1 Sialidase-deficient cells
12/30/1998	EP0698038B1 Method of separating glycosylated and non-glycosylated proteins
12/30/1998	EP0686164B1 Intrinsic inhibitors of aldose reductase
12/30/1998	EP0633945B1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN
12/30/1998	EP0592478B1 Use of lipases to produce drugs
12/30/1998	EP0584273B1 Antibody recognizing endothelial cell ligand for leukocyte cr3
12/30/1998	EP0584175B1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual
12/30/1998	EP0571474B1 Orthomolecular method of treating sickle cell disease
12/30/1998	EP0539522B1 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease
12/30/1998	EP0463059B1 Allergenic proteins from ragweed and uses therefor
12/30/1998	CN1203633A Diagnosis of susceptibility to cancer and treatment thereof
12/30/1998	CN1203632A P16 expression constructs and their application in cancer therapy
12/30/1998	CN1203603A Therapeutic compounds comprised of anti-FC receptor antibodies
12/30/1998	CN1203602A Acylated enol derivatives of 'alpha'-ketoesters and 'alpha'-ketoamides
12/30/1998	CN1203532A Method for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product
12/30/1998	CN1203531A Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (GDNF) protein product
12/30/1998	CN1203238A Novel insulin derivatives having rapid onset of action
12/30/1998	CN1203105A Process for preparing medicine for curing intractable psoriasis
12/30/1998	CA2594375A1 Bovine adenovirus type 3 genome
12/30/1998	CA2304925A1 Borrelia burgdorferi polynucleotides and sequences
12/30/1998	CA2296814A1 Treponema pallidum polynucleotides and sequences
12/30/1998	CA2296002A1 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens
12/30/1998	CA2295877A1 Disease related nucleotide kinases
12/30/1998	CA2295210A1 Prolactin secretion modulator
12/30/1998	CA2295200A1 Receptor kinase, bin1
12/30/1998	CA2294651A1 Surface exposed proteins from chlamydia pneumoniae
12/30/1998	CA2294646A1 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use
12/30/1998	CA2294611A1 Complexes for transporting nucleic acid into higher eukaryotic cells
12/30/1998	CA2294568A1 Lyme disease vaccines
12/30/1998	CA2294464A1 Treatment of insulin resistance
12/30/1998	CA2294169A1 Therapeutic method for management of diabetes mellitus
12/30/1998	CA2294154A1 Cd154 blockade therapy for pancreatic islet tissue transplantation
12/30/1998	CA2294138A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome
12/30/1998	CA2293327A1 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis
12/30/1998	CA2292415A1 B7-binding molecules for treating immune diseases
12/29/1998	US5854413 Synaptogyrin homolog
12/29/1998	US5854412 Chemokine N-terminal deletion mutations
12/29/1998	US5854411 Human chloride channel
12/29/1998	US5854404 Antitumor substance extracted from grifola
12/29/1998	US5854403 Method for isolation of highly pure von Willebrand Factor
12/29/1998	US5854402 Antibodies against streptococcus
12/29/1998	US5854401 Determination of endometrial receptivity toward embryo implantation
12/29/1998	US5854400 Monoclonal antibodies which neutralize HIV-1 infection
12/29/1998	US5854399 Antibodies specific for human cripto-related polypeptide CR-3
12/29/1998	US5854390 Chromatographic purification of vancomycin hydrochloride by use of preparative HPLC
12/29/1998	US5854388 Angiotensin IV peptides and receptor
12/29/1998	US5854382 Bioresorbable compositions for implantable prostheses
12/29/1998	US5854276 Substance WF16616, process for production thereof, and use thereof
12/29/1998	US5854255 Therapeutic package for the long term reduction of body fat stores insulin resistance hyperinsulinemia and hyperglycemia in vertebrates
12/29/1998	US5854249 Opioid diarylmethylpiperazines and piperidines
12/29/1998	US5854240 Methylene blue for the treatment or prophylaxis of encephalopathy caused by ifosfamide
12/29/1998	US5854231 Pharmaceutical composition for inhibiting the growth of cancers
12/29/1998	US5854221 Endothelial cell proliferation inhibitor and method of use
12/29/1998	US5854220 Glial mitogenic factors, their preparation and use
12/29/1998	US5854217 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
12/29/1998	US5854216 Marker for growth hormone-releasing factor receptors
12/29/1998	US5854215 Modulators of β-amyloid peptide aggregation
12/29/1998	US5854214 Therapeutic uses of bactericidal/permeability increasing protein products
12/29/1998	US5854213 Antifungal cyclohexapeptides
12/29/1998	US5854212 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
12/29/1998	US5854211 Compounds with growth hormone releasing properties
12/29/1998	US5854210 Use of cross-linked hemoglobin in treating subarachnoid hemorrhage
12/29/1998	US5854209 Method for oxygenating tissue having reduced red blood cell flow
12/29/1998	US5854208 Hepatoselective pharmaceutical actives
12/29/1998	US5854207 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
12/29/1998	US5854206 Compounds and methods for treatment and diagnosis of prostate cancer
12/29/1998	US5854205 Therapeutic antiangiogenic compositions and methods
12/29/1998	US5854204 Aβ peptides that modulate β-amyloid aggregation
12/29/1998	US5854203 Tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2
12/29/1998	US5854202 Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same
12/29/1998	US5854071 OP-3- induced morphongenesis
12/29/1998	US5854070 Murine and humanizer 23F2G antibodies and cell lines expressing said antibodies
12/29/1998	US5854051 Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof
12/29/1998	US5854049 Plasmin-resistant streptokinase
12/29/1998	US5854048 Method for treating thromboembolic conditions using thrombolytically active proteins
12/29/1998	US5854046 Human hyaluronidase
12/29/1998	US5854045 Transmembrane tyrosine phosphatase and methods of use thereof
12/29/1998	US5854044 Recombinant pseudomonas exotoxin with increased activity
12/29/1998	US5854043 MEKK-related signal transduction kinases
12/29/1998	US5854029 Method for preparing antihypertensive agent
12/29/1998	US5854028 Compositions comprising IL-11 and methods of making and using IL-11
12/29/1998	US5854027 Process for improving the stability of antibodies
12/29/1998	US5854026 Human growth hormone variant having enhanced affinity for human growth hormone receptor at site 1

1 ... 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 ... 3163